FIELD: medicine. SUBSTANCE: method involves applying biologically active ingredient of Actovegin preparation and Thysol gel in the following ingredient proportion in % by mass: Actovegin solution for making injections is taken in recalculating the active ingredient content in the amount of 0.2-0.3, Thysol makes up the rest to achieve 100%. EFFECT: enhanced effectiveness of treatment; improved tolerability; accelerated treatment course.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF POSTOPERATIVE COMPLICATIONS IN CHILDREN WITH OBSTRUCTIVE UROPATHIES | 2010 |
|
RU2427384C1 |
| HEMOSTIMULANT AND PHARMACEUTICAL COMPOSITION AND METHOD FOR HEMOPOIESIS STIMULATION | 2011 |
|
RU2482869C1 |
| METHOD OF TREATMENT OF MAXILLOFACIAL REGION PHLEGMONS | 1997 |
|
RU2129865C1 |
| METHOD OF TREATMENT OF ACUTE VIRAL FACIAL NERVE NEUROPATHY | 2007 |
|
RU2348401C2 |
| METHOD OF TREATMENT OF MULTIPLE ORGAN FAILURE SYNDROME | 2019 |
|
RU2717070C1 |
| METHOD FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS IN CHILDREN BY OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL | 2011 |
|
RU2470629C1 |
| METHOD FOR PREDICTING THE COURSE OF PRIMARY MEDIASTINAL B-LARGE CELL LYMPHOMA | 2021 |
|
RU2772187C1 |
| METHOD OF TREATING ANEMIAS OF VARIOUS GENESIS | 2008 |
|
RU2387404C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RECURRENCE OF DIFFUSE LARGE B-CELL LYMPHOMA | 2021 |
|
RU2758126C1 |
| METHOD FOR TREATMENT OF PNEUMONIA IN NEWBORNS | 2003 |
|
RU2239450C1 |
